Sensitivity and specificity of a utility model of the detection of diabetic neuropathy
Main Article Content
Keywords
Diabetic neuropathies, Diabetic foot, Diagnostic techniques and procedures, Sensitivity and specificity
Abstract
Objective: to determine whether a utility model can be used with acceptable sensitivity and specificity for the diagnosis of diabetic peripheral neuropathy (DPN).
Methods: cross sectional study, non-probability sampling, in 381 type 2 diabetic patients with diabetic foot risk. To determine the DPN, it was evaluated the protective sensation in 10 sites on the foot. It was a positive diagnosis if three or more points showed insensitivity at the touch of the skin with Semmes-Weinstein monofilament (SWM). Monofilament was compared to the utility model (MMU); the diagnostic methods of application were the same for both.
Results: mean age was 62 years, 11 years of development of DM, mean body mass index of 29 kg/m2, average glucose 129 mg/dL (78-264 mg/dL). With sensitivity of 73.68 %, 97.67 % of specificity, positive predictive value 77.78 %, negative predictive value 97.10 %, the positive likelihood ratio was 31.59 and the negative likelihood ratio 0.27.
Conclusion: currently, diagnostic devices for tactile sensory loss are not readily available in our country; therefore, the results of this research will help to make the diagnosis of the MMU timely, inexpensive and easily accessible.
References
Tan LS. The clinical use of the 10 g monofilament and its limitations: a review. Diabetes Res Clin Pract. 2010;90(1):1-7. Epub 2010/07/27.
World Health Organization. Diabetes fact sheet. [Consultado el 19 de julio del 2011]. Disponible en http://www.who.int/mediacentre/factsheets/fs312en/
Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007;3(1):65-76.
Dros J, Wewerinke A, Bindels PJ, van Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009;7(6):555-8.
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719-24.
Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev. 2005;(1):CD001488.
Mendoza-Romo M, Ramírez-Arriola M. Abordaje multidisciplinario del pie diabético. Rev Endocrinol Nutr. 2005;13(4):165-79.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-28.
Feng Y, Schlosser FJ, Sumpio BE. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg. 2011;53(1):220-6 e1-5. Epub 2010 Aug 8.
Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, et al. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res. 2011;133(6):645-9.
Pham H, Armstrong DG, Harvey C, Harkless LB, et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000;23(5):606-11.
American Diabetes Association. Standards of medical care in diabetes 2011. Diabetes Care. 2011;34 Suppl 1:S11-61.
Norma oficial mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes mellitus en la atención primaria. Disponible en http://www.salud.gob.mx/unidades/cdiLnom015ssa.24html
Instituto Mexicano del Seguro Social. Guía de práctica clínica para el diagnóstico y tratamiento de la diabetes mellitus tipo 2 en el primer nivel de atención. México: IMSS; 2009.
Lee S, Kim H, Choi S, Park Y, Kim Y, Cho B. Clinical usefulness of the two-site Semmes-Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci. 2003;18(1):103-7.
Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes care. 2000;23(7):984-8.
Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(11 Suppl):S17-29.
Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot? Diabetes care. 2000;23(7):887.
Ministerio de Sanidad y Consumo. Guía de práctica clínica sobre diabetes tipo 2. España: Ministerio de Sanidad y Consumo; 2008.